“biotech” Archives

in
Entry Author Date Location
OrbiMed Founder Isaly Steps Down After Sexual Harassment Report 12/08/17 New York
Gilead Bets on Cell Therapy Again with $567M Cell Design Labs Deal 12/07/17 San Francisco
Clora Reaps $3.3M to Speed Consultant Hunts by Life Sciences Companies 12/07/17 San Francisco
Metacrine Raises $22M to Advance New Drugs for Chronic Liver Disease 12/07/17 San Diego
Report: Sexual Harassment Claims Hit OrbiMed Founder Sam Isaly 12/06/17 New York
Mitsubishi Tanabe’s Ian Mills Becomes CMO of Outpost Medicine 12/06/17 Indiana
David Spellmeyer Joins Circle Pharma as Chief Scientific Officer 12/06/17 San Francisco
15 For ’18: Key Clinical Data to Watch For Next Year (Part 2) 12/06/17 National
After Humanitarian Honor, Flagship’s Afeyan States Case for Immigration 12/06/17 Boston
Gilman’s Next CEO Trick: Taming CAR-T Cells With Obsidian 12/06/17 Boston
Dynavax Co-founder Takes Long View on Vaccine Development 12/05/17 San Diego
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1) 12/04/17 National
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More 12/01/17 National
Drug Prices, Industry Ties Take Spotlight at HHS Nominee Azar Hearing 11/29/17 National
With Good Data From Rival Migraine Drugs, Doctors Foresee Price Headaches 11/29/17 San Francisco
Chemo Tops Pfizer, Merck KGaA Drug in Big Stomach Cancer Test 11/28/17 New York
Agenda Posted for Xconomy’s What’s Hot in Bay Area Biotech on Dec. 6 11/27/17 National
As AMD Race Tightens, Regeneron’s Second Eye Drug Combo Falls Short 11/27/17 New York
Xconomy’s Diversity Award Winners Show How to Foster an Inclusive Workforce 11/27/17 Boston
Cytokinetics Pivots to Another ALS Drug After Phase 3 Failure 11/21/17 San Francisco
Cardiovate Adds $650K for Device Aiming to Replace Clogged Arteries 11/21/17 Texas
Genomenon Creates Automated, Evidence-Based Cancer Gene Panel 11/21/17 Detroit Ann Arbor
What Steps Should NY Biotech Take in 2018? Share Your View on Dec. 11 11/20/17 New York
Acorda Scraps One Parkinson’s Drug, Puts Its Cash Behind Another 11/20/17 New York
Ed Kaye on Sarepta’s Duchenne Quest, Rising to CEO & His New Startup 11/20/17 Boston
Ionis Pharma Promotes Brett Monia to Chief Operating Officer 11/17/17 San Diego
Celgene Oncology Exec Pehl Named Immunomedics President and CEO 11/17/17 New York
Bio Roundup: ICER Eyes Cost, Azar at HHS, Gates’s ALZ Cash & More 11/17/17 National
Healthcare + A.I. in Boston: The Photos 11/16/17 Boston
FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning 11/16/17 San Francisco
Page 3 of 265 « previous page · next page »